Extended interval dosing of off-label rituximab in multiple sclerosis: A real-world retrospective analysis of clinical efficacy and safety

Multiple Sclerosis and Related Disorders 2026

View at publisher
Authors: Sepideh Paybast, Melika Jameie, Zohreh Tajabadi, Mehdi Azizmohammad Looha, Fatemeh A. Basti, Mobina Amanollahi, Kiana Amani, Marziyeh Mousavi, Seyed Ehsan Mohammadianinejad, Mohammad Hossein Harirchian
DOI: 10.1016/j.msard.2026.106998
Cited by: 1
References: 26

Fields of Study & Subjects

Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders Amyotrophic Lateral Sclerosis Research

Publication details

Journal / source
Multiple Sclerosis and Related Disorders
Publisher
Elsevier BV
Volume
107
Pages
106998–106998
Publication date
14 January 2026
Language
EN